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Detection of Histone-C4 complexes by ELISA 119 Histone-C4 complexes were detected in normal and critically ill patient plasma using Cell 120 death detection ELISA PLUS kit (Roche) with modification. In brief, normal plasma was pre-121 incubated with different concentrations of calf thymus histones for 10 minutes. Histones in 122 plasma were first captured by biotinylated-anti-histone antibody immobilized on streptavidin-123 coated 96 well plates. After extensive washing, rabbit anti-human C4 antibody (Abcam) 124 followed by anti-rabbit-HPR antibody were used to probe histone-C4 complexes. Arbitrary 125 units (AU) were calculated based on the absorbance (450nm) to represent the relative levels 126 of the complexes.
127
Western blotting using HRP conjugated C4 128 In order to double confirm the interaction of C4 with individual histones by different assay, 2 129 µg of H2A, H2B, H3 and H4, 4 µg of H1 and 6 µg of S100P (as control) were subjected to M glycine pH2.2) were used throughout the assay. Five µg/mL of each recombinant histone 142 (H1, H2A, H2B, H3 or H4) in running buffer was captured only on the surface of flow cells 143 Fc (2-6) with Fc1 set as blank. For kinetics, a concentration series C4 was injected at a flow 144 rate of 10 µl/min over both captured histone surface and reference surface (blank) at 20 o C.
145
Kds were calculated using software provided by the manufacturer.
146

Complement activity assay 147
The effect of histones on complement activity in the three pathways was measured using 148 COMPL300 Total Complement Functional Screen kit from Wielisab (Sweden). Briefly, 149 mixtures of the reaction were added to strips of wells for classical pathway (CP) estimation, 150 that were precoated with IgM, strips for alternative pathway (AP) determination were coated 151 with LPS, while Mannan binding lectin pathway (MBL) strips were coated with mannan.
152
Normal human sera were diluted 1/101 (CP and MBL) and 1/18 (AP) assay in specific kit 153 buffers, to ensure that only the pathway in question was activated.(30) After one hour of 154 incubation at 37 °C then washing the strips, alkaline phosphatase-conjugated antihuman C5b-155 9 was added before incubation at room temperature for 30 min. Additional washing was 156 performed, the substrate was added, and the wells were incubated for 30 min. Finally, 157 absorbance values were read at 405 nm. In each assay, standard positive and negative control 158 sera provided in the kit were used. The complement activity for each pathway was expressed 159 as a percentage of the activity of the calibrating serum. C3a and C5a were measured using 160 C3a and C5a ELISA kits (e-Bioscience). C5b-9 induced by zymosan (Comp Tech) was 161 measured using an ELISA kit from Quidel Corporation, USA. Cell viability assay 175 Viability was assessed using a WST-8 cell proliferation assay kit (Enzo Life Sciences), as 176 described previously(31). Briefly, 5x10 4 cells were seeded into each well of a 96-well plate 177 and grown until fully confluent (24 hours). Cells were treated with histones at 100 µg/ml with 178 and without different concentrations of C4 (10-300 µg/ml) for 1 hour. After treatment, the 179 medium was changed to a fresh 100 μl growth media and 10 µl of WST-8 dye was added to 180 each well, followed by further incubation for 2 hrs. Viability was assessed by measuring the 181 absorbance at 450 nm against a reference 650 nm using a microplate reader (Multiskan 182 Spectrum, Thermoelectron Corporation). Viability of untreated cells was set as 100% for 183 comparison.
184
Statistical analysis 185
Intergroup differences were analysed using ANOVA followed by Student-Newman-Keuls test. Two 186 group comparisons with or without treatment used Student's t test unless otherwise specified. 187
Results
188
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Free histones exist in circulation and can form complexes with complement C4
189
Although it is known that nucleosomes can be released after cell death or NETs Figure 1C and 1D). CRP has been reported to be a major histone-binding protein 203 that neutralises histone toxicities(37). As to complement C4, we could detect histone-C4 204 complexes in normal plasma spiked with calf thymus histones ( Figure 1E ) and also in plasma 205 from critically ill patients with high circulating histone levels ( Figure 1F ), confirming that 206 histones form complexes with C4 in vivo. In this study, we further investigated the 207 interaction of histones with C4 and its potential biological roles and significance.
208
Individual histones bind to complement C4 with different affinity 209 To determine the relative binding extents of individual histones to C4, equal molar 10 shows that H3 and H4 predominantly bound to C4 and to a lesser extent H1 and H2B, with 213 H2A-C4 binding undetectable using this method. To determine the comparative binding 214 strengths under physiological conditions, we used surface plasmon resonance (SPR, Biocore 215 X-100) ( Figure 2B-F) . Table 1 shows that H3 (K D = 0.760.12 nM) and H4 (K D = 0.910.07 216 nM) had much higher binding affinity than equal molar concentrations of H1 (K D = 217 7.260.80 nM) and H2B (K D = 9.451.43 nM), with weak binding to H2A (K D = 12.670.59 218 nM).
219
Histones dramatically inhibit classical and lectin but not alternative pathways 220 To investigate functional consequence, we used a Complement functional screen kit to 221 measure the effects of histones on the activation of classical, MBL and alternative pathways.
222
Pre-incubation of different concentrations of calf thymus histones with human serum 223 significantly reduced the production of MAC by activated classical and MBL pathways.
224
Significant reduction could be detected at 10 μg/ml histones, and only trace amount of MAC 225 could be formed in the presence of 50 μg/ml histones ( Figure 3A) . In contrast, histones 226 showed much less effect on the alternative pathway and 50 μg/ml histones only reduced 227 MAC about 20%. To evaluate the overall effect of histones on complement activation in 228 human serum, zymosan was used to activate complement in the presence or absence of 229 histones. We found that histones at 50 μg/ml could significant inhibit the production of MAC 230 induced by zymosan ( Figure 3B ). We also assessed the role of individual histones in the To demonstrate the specificity of histones on complement activation, anti-histone H4 and 236 non-anticoagulant heparin that have been shown to specifically inhibit histone toxicity both in 237 vitro and in vivo (11, 38) , were used. Heparin could reverse the inhibition of both classical and 238 MBL pathways by all individual histones ( Figure 4A, B) , whist anti-histone H4 could 239 significantly rescue the H4-inhibited complement activation of both pathways (Figure 4C, D) . 240 Those data demonstrated that the effect of histones on complement inactivation was specific 241 to histones. To clarify the molecular mechanism of histone-inhibited complement activation through 245 interaction with C4, the effect of histones on the cleavage of C4 to C4b and C4a by C1s, a 246 process of C4 activation, was investigated. We found that histones showed no effect on the 247 production of C4a (Figure 6 A-B) , indicating histone binding does not affect the ability of 248 C1s to cleave C4 protein. Further investigation showed that histones bind to C4b but not C4a 249 ( Figure 6C ). However, in the presence of histones, the production of C3a and C5a were 250 significantly reduced in the classical and MBL pathways but not the alternative pathway Figure 5A, B) . However, the zymosan-induced complement activation could be 260 recovered by 300 μg/ml C4 from 25% to 70% of total activity in the presence of 20 μg/ml 261 histone H4 protein ( Figure 5C ). This observation suggests that histones may also target other 262 components of the complement system rather than C4 alone. On the other hand, C4 protein (Figure 7) . Histones strongly bind to C4 but do not affect C4 activation 275 because there is no difference in C4a production in the presence or absence of histones.
276
Histones binds to C4b but not C4a, therefore their major effect is to reduce the activity of C3 277 and C5 convertase, as indicated by reduction of C3a and C5a, the products of C3 and C5 278 activation. One mechanism could be the interruption of the convertase formation and the 279 other could just affect the catalytic activity even though the complexes are formed. Since the 13 and C5 activation as well as the MAC formation. This finding suggests that C4 is a major 284 target of the complement system. However, excess of C4 could not fully restore the 285 complement activation in the presence of histones. This finding suggests that histones may 286 have more targets on those pathways, such as C1 or C2 (Figure 7) . This needs further 287 investigation.
288
It is known that circulating C4 is about 0.4 mg/ml, but no histones could be detected in blood 
Figure legends
